Antibody drug conjugates (ADC): an ideal synergy for cancer therapy
Dr. Robert Karanja
Biolinx Africa, Kenya
Presentation
Building an open innovation framework for cancer research and commercialization in Africa
Dr. Hudson Alakonya
Cold Springs Harbor Laboratory, USA
Integrated Cancer Research Foundation, Kenya
Presentation
Generation of PDAC-specific antibodies using organoid screening platform
Dr Nikita Muthuuri
Vectorgram Health, Kenya
Presentation
AI in breast cancer screening: insights from radiologists in a multi-site Kenyan study
Dr. Nicholas Okumu
Kenyatta National Hospital, Kenya
Presentation
The role of artificial intelligence in enhancing orthopedic oncology across the cancer care continuum
Dr. Bikham Babu Sujana
Eldoret Oncology and Associates, Kenya
Presentation
Rising strong: resilience and growth in Kenyan women facing breast and gynecologic cancers
Dr. George Ngondi Michuki
NextGen Molecular Lab, Kenya
Presentation
From blood to treatment: how pharmacogenomics is shaping cancer treatment in Kenya
Dr. Omar Abdihamid
Garissa Cancer Centre, Kenya
Presentation
Reaching the unreached: lessons from Kenya’s decentralized cancer care journey
Dr. Rachel Githiomi
Regional Society of Blood Transfusion, Kenya
Presentation
Local genomic profiling and precision medicine in oncology
Dr. Francis Makokha
Mount Kenya University, Kenya
Presentation
Strengthening cancer research through training and digital innovation
Dr. Fiona Okonjo
NanoSyrinx, United Kingdom
Presentation
TBD
Dr. Lucas Nyabero
Elara Health Innovations Inc., Kenya
Presentation
Unlocking the power of genomics & pharmacogenomics for personalized, equitable, and sustainable universal health care
Gift Gwawawa
University of Oxford, United Kingdom
Presentation
Orchestrating nuclear mechanotransduction: emerging roles of JIP3, pJNK and ATR in cellular responses and cancer
Dr. Stefanie Harsch
University of Freiburg, Germany
Integrated Cancer Research Foundation, Kenya
Presentation
Promoting cancer health literacy in Kenya: a promising approach using online cancer surVivors' lived experiences
Dr. Carolyn Muruthi
Aga Khan University, Kenya
Presentation
Impact of the modified ASCO/CAP cut-off on hormone receptor expression and molecular subtypes of breast cancer: a systematic review of evidence from Kenya
Dr. Tyrus Omondi Swaya
Masinde Muliro University of Science & Technology, Kenya
Presentation
Laboratory gaps and the evolution in the diagnosis of prostate cancer in Kenya
Dr. Victor Oria
Biotech Research & Innovation Centre, Denmark
Integrated Cancer Research Foundation, Kenya
Presentation
Beyond angiogenesis: tumor endothelial cells as drivers of metastasis initiation
